NCT01998178: Immune Response and Safety Study of Human Papillomavirus (HPV) Vaccine in HIV-infected Pre-adolescent in Kenya |
|
|
| Active, not recruiting | 4 | 180 | RoW | Quadrivalent HPV Vaccine, Gardasil | Kenyatta National Hospital, University of Washington, Merck | Genital Warts, Cervical Cancer | 08/15 | 12/15 | | |
